Neurosteroid-induced hyperalgesia through a histamine release is inhibited by progesterone and p,p′-DDE, an endocrine disrupting chemical
- 1 April 2003
- journal article
- Published by Elsevier in Neurochemistry International
- Vol. 42 (5) , 401-407
- https://doi.org/10.1016/s0197-0186(02)00135-3
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 19 references indexed in Scilit:
- Anatomical and physiological evidence for involvement of tuberoinfundibular peptide of 39 residues in nociceptionProceedings of the National Academy of Sciences, 2002
- The interaction between neuroactive steroids and the σ1 receptor function: behavioral consequences and therapeutic opportunitiesBrain Research Reviews, 2001
- Environmental Signaling: What Embryos and Evolution Teach Us About Endocrine Disrupting ChemicalsEndocrine Reviews, 2001
- Reduced antinociception and plasma extravasation in mice lacking a neuropeptide Y receptorNature, 2001
- Neurosteroids: Biosynthesis and Function of These Novel NeuromodulatorsFrontiers in Neuroendocrinology, 2000
- Neurosteroids: From Definition and Biochemistry to Physiopathologic FunctionPublished by Springer Nature ,1999
- Neurosteroid Antagonists of the GABAA ReceptorsPublished by Springer Nature ,1999
- Persistent DDT metabolite p,p'–DDE is a potent androgen receptor antagonistNature, 1995
- A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesiaPAIN®, 1988
- Ethical guidelines for investigations of experimental pain in conscious animalsPAIN®, 1983